Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit
Authors:
- L.E. RosengrenLRL.E. Rosengren
- J. LyckeJLJ. Lycke
- O. AndersenOAO. Andersen
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 133 (1-2) , 61-65
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designsJournal of the Neurological Sciences, 1994
- A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adultsJournal of Neuroscience Methods, 1994
- Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-upBrain, 1993
- A sensitive ELISA for glial fibrillary acidic protein: application in CSF of childrenJournal of Neuroscience Methods, 1992
- Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathologyClinica Chimica Acta, 1986
- High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalusJournal of the Neurological Sciences, 1985
- Enzyme‐Linked Immunosorbent Assay for the Human Glial Fibrillary Acidic Protein Using a Mouse Monoclonal AntibodyJournal of Neurochemistry, 1985
- Epstein-Barr Virus Infection and Antibody Synthesis in Patients With Multiple SclerosisArchives of Neurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- An acidic protein isolated from fibrous astrocytesBrain Research, 1971